CalciMedica, Inc.: CalciMedica Reports Third Quarter 2024 Financial Results and Provides ...
Additional positive data, including a win ratio analysis, announced from CARPO Phase 2b trial of Auxora in acute pancreatitis (AP); Company expects to be in a position ...